Condition (MeSH)
Cryptogenic Organizing Pneumonia
ClinicalTrials.gov lists 3 trials for Cryptogenic Organizing Pneumonia or a narrower condition beneath it. Biogen has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Cryptogenic Organizing Pneumonia itself; the rest are tagged with a narrower condition beneath it.
When did Cryptogenic Organizing Pneumonia trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2020 | 1 |
| 2014 | 1 |
| 2011 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Cryptogenic Organizing Pneumonia trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 2 |
| Observational | 1 |
How many Cryptogenic Organizing Pneumonia trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Cryptogenic Organizing Pneumonia trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Biogen | 1 |
Which serious adverse events do Cryptogenic Organizing Pneumonia trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Pneumonia | 6 | 1 |
| Fluid overload | 3 | 1 |
| Hypoxia | 3 | 1 |
| Pulmonary arterial hypertension | 3 | 1 |
| Pulmonary hypertension | 3 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Cryptogenic Organizing Pneumonia? (14)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| [Medical prevention and treatment of radiation-induced pulmonary complications]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2017 | Yes |
| T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors. | Haematologica | 2007 | Yes |
| Cryptogenic organising pneumonia. | The European respiratory journal | 2006 | Yes |
| Diagnostic approach to the patient with diffuse lung disease. | Mayo Clinic proceedings | 2002 | Yes |
| Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia. | Chest | 2000 | Yes |
Showing 5 of 14 publications.
Prevalence (12)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Cryptogenic organizing pneumonia | Point prevalence | 1-9 / 1 000 000 | Spain | Not stated | Exact |
| Cryptogenic organizing pneumonia | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Cryptogenic organizing pneumonia | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Cryptogenic organizing pneumonia | Point prevalence | 1-9 / 1 000 000 | Greece | Not stated | Exact |
| Cryptogenic organizing pneumonia | Point prevalence | 1-9 / 1 000 000 | Greece | Not stated | Unspecified |
Showing 5 of 12 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Cryptogenic organizing pneumonia | 1302 | Exact | Orphadata Science knowledge files, Product 1 |
| Cryptogenic organizing pneumonia | 1302 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.